Early Extubation by ECCO2R Compared to IMV in Patients with Severe Acute Exacerbation of COPD

NCT03584295 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

COPD Exacerbation

Interventions

DEVICE: Extracorporeal carbon dioxide removal
OTHER: Conventional Care

Sponsor

Xenios AG

Collaborators

[object Object]